by SXHH Marketing | Jun 12, 2026 | Uncategorized
For over 12 years, women have trusted HerKare to help guide them through some of life’s biggest hormonal changes, from perimenopause to menopause to low energy, weight changes, mood shifts, and more.
Now, that care is evolving under one unified name: SynergenX.
Over the next year, HerKare clinics along with Low T Centers across the country will slowly transition to the SynergenX brand. While the name and look may change, our commitment to women’s wellness remains the same.
This transition reflects the continued growth of a company focused on helping you feel healthier, more confident, and like yourself again through personalized, medically guided care.
Since 2016, SynergenX has worked to create a more supportive and individualized approach when it comes to wellness. For many women, hormonal changes during perimenopause and menopause can affect nearly every part of daily life. And at SynergenX, care is made to address the full picture, not just a single symptom.
In addition to hormone therapy, SynergenX continues to expand services for women through medically guided weight management, wellness therapies, and ongoing support designed to help you feel your best at every stage of life.
Over the years, hundreds of thousands of women have trusted HerKare with their care. Many women find themselves at HerKare feeling exhausted and disconnected from the version of themselves they once knew. And these women leave feeling more balanced, energized, and confident in their health journey. For CEO Wayne Wilson, these experiences continue to drive the company’s mission forward:
“Helping patients feel like themselves again is one of the most meaningful things we can do in healthcare. This transition reflects who we are today and where we are going in the future. The SynergenX brand represents our commitment to personalized care, innovation, and helping patients become the healthiest, strongest versions of themselves.”
This transition to the SynergenX brand will happen slowly across clinic signage, websites, communications, and digital platforms over the coming year. If you are a patient, you can continue to expect the same providers, the same care teams, and the same compassionate approach to wellness throughout the process.
While the HerKare name is changing, our mission remains the same: Helping women feel balanced, supported, confident, and empowered in their health.
by SXHH Marketing | Feb 12, 2026 | Uncategorized
By Carolyn Moyers, D.O., FACOG
Are you taking, or considering, hormone replacement therapy (HRT) to treat bothersome menopause symptoms? How does this impact your heart health?
There has been controversy around hormone replacement therapy (HRT) over past decades. HRT has gone from a standard treatment for hot flashes and other symptoms of menopause to a decision each woman must weigh carefully based on her body and health history.
Some research has linked HRT to increased risk of heart disease, stroke, blood clots, and breast cancer, while other studies have shown hormone replacement may lower the risk of osteoporosis and improve other aspects of health.
Read the literature on this and your head will be spinning. Recent studies are showing benefits to women, particularly women who use HRT close to the onset of menopause, although, the duration of therapy and relationship to heart health awaits further study.
Hormone replacement therapy – estrogen, estrogen + progesterone, and dare you add testosterone – It’s all so confusing. “What are my risks?” patient’s often ask.
Risks in perspective
- The risk of heart disease to an individual woman taking hormone therapy is very low.
- Your individual risk of developing heart disease depends on many factors, including family medical history, personal medical history and lifestyle practices.
- If you stopped having periods or lost normal function of your ovaries before age 40, you have a different set of heart and blood vessel (cardiovascular) health risks compared with women who reach menopause near the average age of about 50. This includes a higher risk of coronary heart disease.
Talk to your provider about your personal risks. If you’re at low risk of heart disease, and your menopausal symptoms are significant, hormone therapy is a reasonable consideration.
HRT risks may vary depending on:
- Whether estrogen is given alone or with a progesterone
- Your current age and age at menopause
- The dose, type of estrogen and how you take it (oral, transdermal, transvaginal)
- Other health risks, such as your family medical history and cancer risks
Who should NOT take hormone therapy?
If you’ve already had a heart attack, HRT is not for you. If you already have heart disease or you have a history of blood clots, the risks of hormone therapy have been clearly shown to outweigh any potential benefits.
Menopause symptoms: What are they and why are women seeking treatment?
As women age, they find themselves with sudden sensation of extreme heat in the upper body, face, neck and chest, referred to as a hot flush. The unwelcome sweating, flushing, chills, clamminess, anxiety and even heart palpitations accompany this. These unwelcome vasomotor symptoms vary in how often and how long they last. Patients report symptoms lasting anywhere from 4-10 years around menopause. While menopause is defined as not having cycles for 12 months, symptoms do not end with the end of menstrual cycles. Sigh . . . The low estrogen levels leads to changes in the vagina– vaginal or vulvar dryness, discharge, itching and painful intercourse. The lack of estrogen leads to a loss of superficial epithelial cells, vaginal folds and elasticity and narrowing and shortening of the vagina. In addition, the pH of the vagina even changes and can lend to more urogenital infections. “Really?!” I hear you asking yourself. All these changes have women feeling frustrated, fatigued and often questioning their sanity.
HRT and the Heart
The consensus at this time is that menopausal hormone replacement therapy should not be used for the primary prevention of coronary heart disease. There is some data that supports a “timing hypothesis” – meaning, the cardiovascular benefit is most profound when HRT is used at the onset of menopause versus someone who has been menopausal 10 years or more. We do not know the affects of the duration of HRT at this time.
Your provider will likely recommend a heart healthy lifestyle to reduce your cardiovascular risks.
- Don’t smoke or use tobacco products.
- Get regular physical activity.
- Eat a healthy diet focusing on fruits, vegetables, whole grains and low-fat protein.
- Maintain a healthy weight.
- Get regular health screenings to check your blood pressure and cholesterol levels to detect early signs of heart disease.
We also understand that quality of life must be considered when prescribing HRT. Lifestyle changes and over the counter solutions don’t always provide the relief you so desperately desire. HRT must be individualized based on each woman’s risk-benefit ratio and clinical presentation.
How is HRT different at HerKare?
A customized treatment plan specific to each patient is designed to improve symptoms. The goal is to achieve a balance of hormones, vitamin deficiencies, and thyroid function.
A balancing act
Among U.S. women, nearly 1 in 4 deaths each year is due to heart and blood vessel (cardiovascular) disease. Women of all ages should take heart disease seriously.
Most healthy women can safely take HRT for menopausal symptoms without significantly increasing the risk of heart disease. If you experience classic menopausal symptoms talk to your provider about how you can relieve troublesome symptoms without putting your health at risk.
by SXHH Marketing | Dec 12, 2025 | Hormone Replacement Therapy, Menopause, Wellness
For years, menopausal hormone therapy carried a warning label that did more than flag risk. It shaped perception. It ended conversations before they started. For many women, it quietly reinforced the idea that relief came with a price that was simply too high.
The FDA has now removed the black box warning from certain menopausal hormone therapy products, and the significance of that change goes beyond labeling. It signals a long-overdue recalibration in how women’s hormone care is understood.
How we got here
The warning traces back to the Women’s Health Initiative studies published in the early 2000s. Those findings linked specific hormone therapies to increased risks of blood clots, stroke, and breast cancer in certain populations.
What mattered then, and still does, is context.
The study primarily examined older women, often more than a decade past menopause, and prescribed oral hormone formulations that reflected clinical norms of the time. The results were meaningful, but their application became sweeping. A single narrative took hold, flattening nuance and leaving little room for clinical judgment or individual variation.
Why the warning no longer made sense
Two decades later, menopausal hormone therapy looks fundamentally different.
Research has continued. Clinical practice has evolved. The conversation around timing, formulation, dosing, and patient selection has grown more precise. We now understand that hormone therapy initiated closer to menopause carries a different risk profile than therapy started years later. We understand that delivery method matters. We understand that cardiovascular and metabolic health cannot be separated from hormone decisions.
The FDA’s decision to remove the black box warning reflects this accumulation of knowledge. It acknowledges that the label no longer aligned with how menopausal hormone therapy is prescribed or evaluated today.
Why this matters to women now
The black box warning informed, but it also created fear in women who could have benefited from HRT.
For many women, it became shorthand for danger, reinforcing hesitation even as symptoms mounted. Brain fog. Disrupted sleep. A persistent sense of being off balance. Mood changes that felt unfamiliar. A body that no longer responded the way it once did.
The removal of the warning does not suggest that hormone therapy is universally appropriate. What it does is restore the possibility of discussion without fear of being the loudest voice in the room.
What has not changed
Hormone therapy remains a medical intervention that requires discernment.
Women considering menopausal hormone therapy should expect:
-
An individualized medical evaluation
-
Careful attention to health history and risk factors
-
Dosing that reflects both symptoms and physiology
-
Ongoing monitoring over time
The shift is not toward casual prescribing. It is toward care that reflects current science rather than outdated generalizations.
Where HerKare stands
At HerKare, menopausal hormone therapy is approached as a collaborative, patient-focused process. Care is shaped by how a woman feels, what her labs reveal, and how her health evolves.
by SXHH Marketing | Oct 23, 2025 | Hormone Replacement Therapy, Menopause, Sleep, Wellness
Every October, National Menopause Awareness Month encourages women to understand the changes happening in their bodies, and to know that help and hope are available.
Menopause is a natural life stage, but that doesn’t mean it’s easy to navigate. At HerKare, we believe every woman deserves care, compassion, and accurate information during this transition.
What Is Menopause?
Menopause marks the end of a woman’s menstrual cycles, confirmed after 12 months without a period. The average age is 51, but symptoms can begin years earlier during perimenopause.
As estrogen and progesterone levels fluctuate, your body may react in ways that feel unfamiliar. Recognizing these changes early can make them easier to manage.
Common Signs and Symptoms
-
Hot flashes or night sweats
-
Irregular or missed periods
-
Mood changes or anxiety
-
Fatigue and low motivation
-
Vaginal dryness or discomfort
-
Weight gain or slower metabolism
-
Hair thinning or dry skin
-
Memory lapses or “brain fog”
Every woman’s experience is unique. Some may only notice mild changes, while others face symptoms that affect sleep, work, and relationships.
Why Menopause Awareness Matters
For decades, conversations about menopause were quiet, even taboo. Women were told to “push through.” Today, Menopause Awareness Month reminds us that these symptoms are real—and treatable.
When hormones decline, it can impact bone health, heart health, metabolism, and mental well-being. Awareness leads to proactive care and better long-term health.
“At HerKare, our message is simple: Menopause isn’t the end of feeling like yourself—it’s a new beginning,” says Michael Seay, MSN, APRN, NP-C. “When you understand your hormones, you can take control of your energy, mood, and confidence again.”
How HerKare Can Help
HerKare offers a full spectrum of care for women in perimenopause and menopause, including:
-
Comprehensive hormone testing
-
Individualized hormone replacement therapy (HRT)
-
Lifestyle and nutrition guidance
-
Ongoing follow-up care to track progress and fine-tune your treatment
Our goal is to help you rediscover balance, clarity, and comfort, so you can feel strong and joyful through every stage of life.
This Menopause Awareness Month, make yourself a priority. Schedule a free consultation and start feeling like you again.
by SXHH Marketing | Oct 15, 2025 | Hormone Replacement Therapy, Menopause, Wellness
Every October, we come together to honor those affected by breast cancer and to raise awareness that empowers women, not frightens them.
At HerKare, we know that breast cancer awareness also means supporting women’s confidence in their health choices. One of the biggest sources of confusion and fear is hormone replacement therapy (HRT) and whether it increases breast cancer risk.
It’s a complicated topic, and it’s easy to feel torn between wanting relief from menopausal symptoms and wanting to protect your long-term health. So this Breast Cancer Awareness Week, let’s look at the real science behind HRT and separate fear from fiction.
Myth 1: “HRT Always Causes Breast Cancer”
Fact: The truth is more nuanced. Some forms of HRT, especially those that combine estrogen and progesterone, have been shown to slightly increase the risk of breast cancer when used long-term (usually more than five years).
However, estrogen-only HRT, which is prescribed to women who’ve had a hysterectomy, has not shown the same increase. Some studies even suggest it might lower risk in certain cases.
And here’s the important part:
When therapy is stopped, the risk gradually returns to normal over the next few years.
Myth 2: “If You Have a Family History of Breast Cancer, HRT Is Off-Limits”
Fact: A family history doesn’t automatically disqualify you from using HRT.
For many women, especially those using short-term, low-dose therapy, the added risk is minimal, even with family history.
Your provider can help you understand your personal risk profile and choose a plan that works for your body and your comfort level.
Myth 3: “All HRT Is the Same”
Fact: Hormone therapy isn’t one-size-fits-all.
The type of hormones, the way they’re delivered (pill, patch, gel, or cream), and the dose all make a difference.
For example, transdermal estrogen (through the skin) and bioidentical hormones may offer similar benefits with a lower impact on breast cancer risk compared to some older formulations.
Myth 4: “Once You Take HRT, You’ll Always Be at Higher Risk”
Fact: Thankfully, that’s not true.
After stopping HRT, most women’s breast cancer risk returns to baseline within about five years, and often sooner for those who used lower doses.
Myth 5: “Estrogen-Only HRT Is Completely Safe”
Fact: While estrogen-only HRT carries less breast cancer risk, it can increase the risk of uterine cancer in women who still have their uterus, which is why progesterone is added for protection.
The safest HRT plan depends on your complete medical history, which is why individualized care is most important.
People Also Ask
Q: Does HRT increase my risk of breast cancer?
A: Some types may slightly increase risk after several years, especially estrogen-progestin therapy. Estrogen-only therapy has a lower risk profile.
Q: Can women with a family history of breast cancer use HRT?
A: Often, yes, but it’s vital to begin with a personalized plan and close monitoring. Discuss your risk level and hormone options with your healthcare provider.
Q: Does HRT affect mammograms or breast density?
A: It can temporarily increase breast density, which can make imaging less clear. Regular screenings help ensure accurate results.
Q: How long can I safely stay on HRT?
A: Most women can use HRT safely for 3–5 years, though some continue longer under medical supervision if the benefits outweigh the risks.
A Word from Our Medical Team
“At SynergenX, we believe women deserve the full picture — not fear. The risks of hormone therapy are often overstated, and with the right supervision, HRT can help women feel healthy, balanced, and vibrant through menopause and beyond.”
— Michael Seay, MSN, APRN, NP-C
The Bottom Line
For many women, HRT can safely ease the symptoms of menopause (improving sleep, focus, energy, and mood) while the associated breast cancer risk remains small, temporary, and manageable.
If you’re struggling with hot flashes, mood swings, or other menopause symptoms but worried about HRT, remember this:
Knowledge is empowerment. Your provider’s job is to help you find balance, not make you choose between comfort and safety.
This Breast Cancer Awareness Week, take time to schedule your screenings, learn your options, and make informed decisions about your health, your way.
Sources
- Beral V. et al. Type and timing of menopausal hormone therapy and breast cancer risk. The Lancet. 2019;394(10204):1159–1168. The Lancet
- National Institute for Health and Care Research. Risk of breast cancer with HRT depends on therapy type and duration. NIHR Evidence
- NHS. Benefits and risks of hormone replacement therapy (HRT). NHS UK
- Cancer Research UK. Does hormone replacement therapy increase cancer risk? CancerResearchUK.org
- BreastCancer.org. HRT and Breast Cancer Risk. BreastCancer.org
- ICR. Short-term HRT use and family history of breast cancer. icr.ac.uk
